Engineered NLS-PBase system boosts stability and productivity in recombinant cell lines

Yanan Zhou , Yuan Tian , Qingyuan Ran , Qian Ye , Wen-Song Tan

Bioresources and Bioprocessing ›› 2026, Vol. 13 ›› Issue (1) : 59

PDF
Bioresources and Bioprocessing ›› 2026, Vol. 13 ›› Issue (1) :59 DOI: 10.1186/s40643-026-01056-x
Research
research-article
Engineered NLS-PBase system boosts stability and productivity in recombinant cell lines
Author information +
History +
PDF

Abstract

Chinese hamster ovary (CHO) cells constitute the industry-standard platform for the production of complex therapeutic proteins, yet genomic heterogeneity arising from random integration leads to clonal variability and unstable expression, necessitating a robust cell line development process to efficiently isolate stable, high-expressing clones. By employing an optimized integration strategy, recombinant cell line performance can be enhanced through improved genomic stability and increased productivity. In this study, GFP reporter analysis demonstrated that the PiggyBac system significantly boosts the yield of both stable and high-expression clones. Subsequently, transposase modified with a nuclear localization signal (NLS) exhibited superior stability in recombinant cell lines and polyclonal pools. The nucleoplasmin NLS resulted in transgene integration into genomic loci that promote enhanced and more stable expression, thereby improving clonal distribution. Furthermore, this strategy also increased recombinant mAb expression by 97% in pools while enhancing average and specific productivity in derived cell lines. Additionally, recombinant suspension cells generated with the optimized system exhibited comparable performance, with over 50% of minipools showing robust growth. Overall, these findings highlight the promising utility of the NLS-optimized PiggyBac system for improving transgene stability and expression while streamlining the cell line screening process.

Keywords

Stability / Cell line construction / Transposon / PiggyBac system / Nuclear localization signal / Production

Cite this article

Download citation ▾
Yanan Zhou, Yuan Tian, Qingyuan Ran, Qian Ye, Wen-Song Tan. Engineered NLS-PBase system boosts stability and productivity in recombinant cell lines. Bioresources and Bioprocessing, 2026, 13(1): 59 DOI:10.1186/s40643-026-01056-x

登录浏览全文

4963

注册一个新账户 忘记密码

References

[1]

Balasubramanian S, Matasci M, Kadlecova Z, et al.. Rapid recombinant protein production from piggyBac transposon-mediated stable CHO cell pools. J Biotechnol, 2015, 200: 61-69

[2]

Balasubramanian S, Wurm FM, Hacker DL. Multigene expression in stable CHO cell pools generated with the piggyBac transposon system. Biotechnol Prog, 2016, 32: 1308-1317

[3]

Cadiñanos J, Bradley A. Generation of an inducible and optimized piggyBac transposon system. Nucleic Acids Res, 2007, 35: e87-e87

[4]

Cary LC, Goebel M, Corsaro BG, et al.. Transposon mutagenesis of baculoviruses: Analysis of trichoplusia ni transposon IFP2 insertions within the FP-locus of nuclear polyhedrosis viruses. Virology, 1989, 172: 156-169

[5]

Charng YC, Li HP, Chang HC, et al.. Fusion of the transposase with a classical nuclear localization signal to increase the transposition efficiency of ac transposon. Bot Bull Acad Sin, 2004, 45: 267-274

[6]

Dingwall C, Laskey RA. Nuclear targeting sequences — a consensus?. Trends Biochem Sci, 1991, 16: 478-481

[7]

Efthymiadis A, Shao H, Hübner S, Jans DA. Kinetic characterization of the human retinoblastoma protein bipartite nuclear localization sequence (NLS) in vivo andin vitro: a COMPARISON WITH THE SV40 LARGE T-ANTIGEN NLS *. J Biol Chem, 1997, 272: 22134-22139

[8]

Fraser MJ, Cary L, Boonvisudhi K, Wang H-GH. Assay for movement of lepidopteran transposon IFP2 in insect cells using a baculovirus genome as a target DNA. Virology, 1995, 211: 397-407

[9]

Galvan DL, Nakazawa Y, Kaja A, et al.. Genome-wide mapping of PiggyBac transposon integrations in primary human T cells. J Immunother, 2009, 32: 837

[10]

Gu MB, Kern JA, Todd P, Kompala DS. Effect of amplification ofdhfr andlac Z genes on growth and β-galactosidase expression in suspension cultures of recombinant CHO cells. Cytotechnology, 1992, 9: 237-245

[11]

Hicks GR, Raikhel NV (1995) Protein import into the nucleus: an integrated view. Annu Rev Cell Dev Biol 11:155-188. https://doi.org/10.1146/annurev.cb.11.110195.001103

[12]

Huhn SC, Chang M, Jiang B, et al.. Genomic features of recombinant CHO clones arising from transposon-based and randomized integration. J Biotechnol, 2023, 373: 73-81

[13]

Inniss MC, Bandara K, Jusiak B, et al.. A novel Bxb1 integrase RMCE system for high fidelity site-specific integration of mAb expression cassette in CHO cells. Biotechnol Bioeng, 2017, 114: 1837-1846

[14]

Jans DA, Xiao C-Y, Lam MHC (2000) Nuclear targeting signal recognition: A key control point in nuclear transport? BioEssays 22:532–544. 10.1002/(SICI)1521-1878(200006)22:6<532::AID-BIES6>3.0.CO;2-O

[15]

Kawabe Y, Komatsu S, Komatsu S, et al.. Targeted knock-in of an scFv-fc antibody gene into the hprt locus of chinese hamster ovary cells using CRISPR/Cas9 and CRIS-PITCh systems. J Biosci Bioeng, 2018, 125: 599-605

[16]

Koyama Y, Banzai T, Sonezaki S, Kusano K. Stable expression of a heterogeneous gene introduced via gene targeting into the HPRT locus of human fibrosarcoma cells. Biotechnol Bioeng, 2006, 95: 1052-1060

[17]

Kromenaker SJ, Srienc F. Stability of producer hybridoma cell lines after cell sorting: A case study. Biotechnol Prog, 1994, 10: 299-307

[18]

LaCasse EC, Lefebvre YA. Nuclear localization signals overlap DNA- or RNA-binding domains in nucleic acid-binding proteins. Nucleic Acids Res, 1995, 23: 1647-1656

[19]

Li X, Bai Y, Cheng X, et al.. Efficient SSA-mediated precise genome editing using CRISPR/Cas9. FEBS J, 2018, 285: 3362-3375

[20]

Matasci M, Hacker DL, Baldi L, Wurm FM. Recombinant therapeutic protein production in cultivated mammalian cells: current status and future prospects. Drug Discovery Today: Technol, 2008, 5: e37-e42

[21]

Mattia Matasci, Matasci M, Lucia B, et al.. The PiggyBac transposon enhances the frequency of CHO stable cell line generation and yields recombinant lines with superior productivity and stability. Biotechnol Bioeng, 2011, 108: 2141-2150

[22]

Munoz-Lopez M, Garcia-Perez JL. DNA transposons: Nature and applications in genomics. Curr Genomics, 2010, 11: 115-128

[23]

Ng D, Zhou M, Zhan D. Development of a targeted integration Chinese hamster ovary host directly targeting either one or two vectors simultaneously to a single locus using the cre/lox recombinase-mediated cassette exchange system. Biotechnol Prog, 2021

[24]

Owens JB, Urschitz J, Stoytchev I, et al.. Chimeric piggyBac transposases for genomic targeting in human cells. Nucleic Acids Res, 2012, 40: 6978-6991

[25]

Park JY, Lee H, Song ES, et al.. Improvement of Tol2 transposon system by modification of Tol2 transposase. Biotechnol Bioproc E, 2022, 27: 987-994

[26]

Pilbrough W, Munro TP, Gray P. Intraclonal protein expression heterogeneity in recombinant CHO cells. PLoS ONE, 2009, 4: e8432

[27]

Ritter A, Rauschert T, Oertli M, et al.. Disruption of the gene C12orf35 leads to increased productivities in recombinant CHO cell lines. Biotechnol Bioeng, 2016, 113: 2433-2442

[28]

Smith Hms, Hicks GR, Raikhel NV. Importin α- from arabidopsis thaliana is a nuclear import receptor that recognizes three classes of import signals. Plant Physiol, 1997, 114: 411-417

[29]

Solenne Bire, Bire S, Yves D, et al.. PiggyBac transposase and transposon derivatives for gene transfer targeting the ribosomal DNA loci of CHO cells. J Biotechnol, 2021, 341: 103-112

[30]

Verdin P. Top companies and drugs by sales in 2024. Nat Rev Drug Discovery, 2025, 24: 240-240

[31]

Walsh G, Walsh E. Biopharmaceutical benchmarks 2022. Nat Biotechnol, 2022, 40: 1722-1760

[32]

Wang X, Kawabe Y, Kato R, et al.. Accumulative scFv-fc antibody gene integration into the hprt chromosomal locus of chinese hamster ovary cells. J Biosci Bioeng, 2017, 124: 583-590

[33]

Wilson MH, Coates CJ, George AL. PiggyBac transposon-mediated gene transfer in human cells. Mol Ther, 2007, 15: 139-145

[34]

Wurm FM. Production of recombinant protein therapeutics in cultivated mammalian cells. Nat Biotechnol, 2004, 22: 1393-1398

[35]

Yunxiao Ren RXX, Lou X. Research advance and application in the gene therapy of gene editing technologies. Hered(beijing), 2019, 41: 18-27

[36]

Yusa K, Zhou L, Li MA, et al.. A hyperactive piggyBac transposase for mammalian applications. Proc Natl Acad Sci, 2011, 108: 1531-1536

[37]

Zeyda M, Borth N, Kunert R, Katinger H. Optimization of sorting conditions for the selection of stable, high-producing mammalian cell lines. Biotechnol Prog, 1999, 15: 953-957

[38]

Zhao M, Wang J, Luo M, et al.. Rapid development of stable transgene CHO cell lines by CRISPR/Cas9-mediated site-specific integration into C12orf35. Appl Microbiol Biotechnol, 2018, 102: 6105-6117

RIGHTS & PERMISSIONS

The Author(s)

PDF

9

Accesses

0

Citation

Detail

Sections
Recommended

/